查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1848907

高通量篩檢市場（按產品類型、技術、板型、應用和最終用戶分類）—2025-2032 年全球預測

High-Throughput Screening Market by Product Type, Technology, Plate Format, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年高通量篩檢市場規模將成長至 660.5 億美元，複合年成長率為 11.96%。

主要市場統計數據
基準年2024年 267.5億美元
預計2025年 297.9億美元
預測年份：2032年 660.5億美元
複合年成長率（%） 11.96%

高通量篩檢的時代發展強調檢測保真度、自動化靈活性和資料完整性，以加速藥物研發流程

高通量篩檢(HTS) 已從一項小型自動化技術發展成為現代藥物發現和轉化研究的基石，使研究機構能夠以前所未有的規模快速探索化學空間和生物表現型。如今，各實驗室的 HTS 工作流程整合了先進的檢測系統、自動化液體處理和資料管理平台，從而縮短了從標靶識別到先導化合物篩選的時間。隨著各機構力求加速流程並減少研究疲勞，篩檢能力的評判標準也日益多樣化，不僅在於通量，還在於靈活性、檢測保真度以及為下游決策提供資訊的數據品質。

耗材創新、儀器複雜度、服務模式和分析軟體的融合，拓寬了高通量提案(HTS) 的價值主張，使其超越了簡單的大規模檢測。專用實驗室耗材和試劑組等耗材旨在最佳化檢測的穩健性，檢測和液體處理平台的設計也支援微型孔板格式和複雜的基於細胞的讀數。同時，提供檢測開發、驗證和端到端篩檢的服務供應商，使缺乏內部能力的機構能夠快速利用 HTS 能力，而化合物管理和資料分析的軟體工具對於管理篩檢輸出的數量和複雜性至關重要。

此外，化合物管理和數據分析的軟體工具對於管理篩檢結果的數量和複雜性至關重要。這些動態因素共同推動了研發領導者優先事項的重大轉變，他們優先考慮檢測的可擴展性、資料完整性和跨平台互通性。本報告整合了定義學術、臨床和工業領域高通量篩選 (HTS) 策略和能力發展的關鍵技術、監管和商業性促進因素，為尋求將篩檢投資轉化為可衡量的治療和發現成果的決策者提供了清晰的藍圖。

技術整合、進階分析和服務模式正在重塑篩檢工作流程，以實現更高的保真度和轉換相關性

在技​​術日趨成熟、研發模式不斷變化以及對資料品質提升需求的推動下，高通量篩選 (HTS) 領域正在經歷重大變革。微射流和實驗室晶片技術的進步正在大幅降低試劑消費量，並促進了先前無法規模化進行的單細胞和微型化檢測。無標定檢測模式正在與成像和高內涵方法相結合，以創建能夠捕獲表現型複雜性並保持高通量檢測的混合讀數。這些技術進步得益於液體處理精度和孔板規格的改進，這使得在更小的體積內進行更多類型的檢測而無需犧牲可重複性。

除了儀器之外，軟體和數據分析也正在從邊緣工具轉變為高通量篩選 (HTS) 工作流程的核心支柱。與篩選平台整合的化合物管理系統可確保樣本的可追溯性並減少錯誤，而融合機器學習和模式識別的高級數據分析流程則增強了藥物的識別和分類。合約篩檢機構和基於服務的篩檢模式的興起也正在改變藥物的採用模式，使公司無需進行資本密集型投資即可獲得專業的檢測和驗證服務。這種轉變鼓勵了投資組合層面的實驗，並支持了自適應的研發策略。

監管和品質要求日益嚴格，迫使供應商強調檢測驗證、文件記錄和可重複性。因此，決策者越來越青睞能夠提供涵蓋耗材、儀器、服務和軟體的穩健整合解決方案。這些發展的融合正在重新定義高通量篩選 (HTS) 的競爭優勢，使互通性、轉化相關性以及產生可靠數據以加速下游開發的能力變得尤為重要。

關稅主導的採購重組和供應鏈彈性措施正在重新定義篩檢作業中的供應商選擇、採購和平台決策

美國已頒布和提案的2025年關稅，為HTS生態系統內的籌資策略、供應鏈彈性和成本結構帶來了重大考量。某些類別的設備和進口檢測耗材的關稅促使採購團隊重新評估籌資策略，並在特定產品性能需求與跨境貿易的財務和物流影響之間取得平衡。因此，各組織更重視供應商多元化、當地經銷商關係以及更長的前置作業時間規劃，以減輕關稅相關延誤和價格波動帶來的風險。

為了應對關稅壓力，一些金融機構正在與國內製造商和服務提供者加強合作，以對沖供應鏈中斷的風險。這導致人們對可在本地升級和維護的模組化平台的興趣日益濃厚，並加強了對供應商端到端採購路線圖的審查。採購負責人在評估整體擁有成本時也更加謹慎，不僅要考慮初始採購價格，還要考慮維護成本、耗材相容性以及關稅帶來的潛在成本波動。

此外，關稅刺激了籌資策略的創新，包括學術聯盟之間的共同採購，以及利用合約研究夥伴關係在不轉移資本支出的情況下獲得專業知識。這些調整在控制財務影響的同時，也維持了科學發展的動能。展望未來，貿易政策與策略採購之間的相互作用將繼續影響供應商的選擇、平台標準化和高通量測試（HTS）能力的發展。

橫斷面細分分析揭示了產品、技術、板材格式、應用程式和最終用戶動態如何相互作用，從而影響採用和價值實現

細分洞察揭示了差異化的需求促進因素和技術組合，為產品開發和商業化策略提供資訊。在產品類型細分中，專用實驗室耗材、試劑和檢測試劑套件等耗材對於檢測性能至關重要，並且通常是可重複性的差異化因素。涵蓋篩檢、檢測開發和驗證的服務為企業提供了無需大量資本支出即可獲得客製化功能的途徑，而涵蓋化合物管理和數據分析的軟體產品對於將原始篩檢結果轉化為可操作的候選方案至關重要。這些產品層面的動態變化創造了相互依賴的關係，其中耗材最佳化、儀器相容性和軟體工作流程共同決定了端到端檢測的成功。

技術細分凸顯了細胞化驗分析日益成長的重要性，例如螢光成像盤式分析儀檢測和基於報告基因的檢測，這得益於其生物學相關性。實驗室晶片和微射流技術方法的同步發展支持微型化、高內涵檢測，從而減少試劑使用並實現新穎的實驗設計，而無無標定技術則提供了互補的動力學和機制見解。從高密度1536孔盤到384孔和96孔盤，板型細分選擇反映了通量、數據品質和檢測複雜性之間的權衡，高密度板適用於大型化合物庫，低密度板適用於複雜檢測或原代細胞檢測。

應用細分凸顯了藥物研發、基因組學和蛋白​​質組學、分子篩檢以及毒理學和安全性評估對吞吐量、數據保真度和檢測設計的要求各不相同。最終用戶細分錶明，學術和研究機構、受託研究機構、醫院、診斷實驗室以及製藥和生物技術公司在預算週期、監管需求和時間表方面有不同的優先事項。了解這些細分有助於供應商和買家根據每個用戶群的細微需求調整其產品藍圖、服務產品和支援模式。

美洲、歐洲、中東和非洲以及亞太地區的創新生態系統和法規的細微差別將推動差異化的採用和夥伴關係策略

美洲、歐洲、中東和非洲以及亞太地區不同的創新生態系統、法規環境和商業基礎設施塑造了高通量篩選（HTS）的區域動態。在美洲，強大的製藥和生物技術叢集以及先進的學術研究網路支持對尖端設備和綜合服務的需求。轉化研究的投資以及龐大的受託研究機構）基礎創造了協同效應，加速了技術應用和合作篩檢計劃的開展。

歐洲、中東和非洲是一個多元化的地區，嚴格的法規和強大的學術機構推動對檢測驗證和數據品質的高標準。在一些歐洲國家，本地製造能力支撐著彈性供應鏈，跨境合作研究計畫促進了技術轉移和標準化工作。在中東和非洲市場，對診斷能力和區域卓越中心的重點投資正在逐步擴大高階篩檢用戶群。

亞太地區的特點是產能快速擴張，生物技術和製藥製造業投資龐大，國內對設備和耗材的需求不斷成長。亞太國家的國內供應商價格競爭力不斷增強，品質也不斷提升，這迫使跨國供應商調整其區域策略。在所有地區，跨境合作和知識交流正在推動最佳實踐的協調統一。

結合模組化儀器、可靠耗材、檢驗的服務和高級分析的整合供應商策略定義了競爭差異

HTS 生態系統中的主要企業正專注於整合硬體效能、耗材可靠性、服務專業知識和先進軟體功能的整合提案主張。儀器製造商正在擴展模組化產品組合，以支援高密度篩檢和複雜的表現型分析，優先考慮平台互通性和可改造性，使現有工作流程能夠在不造成重大資本變動的情況下進行升級。試劑和實驗室耗材供應商認知到試劑性能直接影響到試劑的可重複性和下游驗證的成功率，因此正在投資改進配方和品管，以降低批次差異並提高檢測之間的一致性。

服務供應商憑藉深厚的檢測開發專業知識、法規級驗證流程以及靈活的合約模式（從獨立宣傳活動到長期夥伴關係）脫穎而出。軟體供應商正在將分析、視覺化和機器學習融入其化合物管理和數據分析解決方案中，以實現更快的命中分類和更豐富的生物學解讀。在整個競爭格局中，隨著企業尋求建立全面的解決方案來解決與吞吐量、資料完整性和跨平台相容性相關的企業痛點，策略和銷售聯盟正變得越來越普遍。

那些能夠應對力採購壓力（例如本地支援基礎設施和總擁有成本透明度）的公司往往會獲得機構投資者的支持。那些投資於與學術中心和合約研究組織 (CRO) 建立合作夥伴關係以檢驗其平台轉化相關性的公司，在轉化研究人員和商業開發者中贏得了信譽。整體而言，最成功的公司會在技術領先地位與卓越服務和務實的部署模式之間取得平衡，從而最大限度地提高不同終端用戶的採用率。

領導者採取切實的策略舉措，推動互通性、區域支援、檢驗嚴謹性和靈活的商業模式，以贏得採用

隨著高通量定序 (HTS) 的發展，產業領導者應優先考慮互通性、可重複性和策略夥伴關係關係，以獲取價值。投資平台模組化和升級途徑可以減少採用者的摩擦，並維護與裝置量的關係。同樣，建立強大的耗材品管標準和透明的驗證通訊協定，可以與要求跨站點和研究可重複性的研發買家建立信任。透過使產品藍圖與最終用戶工作流程和相容性要求保持一致，供應商可以降低採用門檻，並提升終身客戶價值。

建立區域服務中心和值得信賴的經銷商網路可以降低採購風險，並應對關稅帶來的供應鏈壓力。與學術中心和合約研究組織 (CRO) 的合作可以加速現實世界的檢驗，擴展可尋址用例，並創建通往長期商業關係的轉診途徑。在軟體方面，將分析和機器學習融入化合物管理和數據分析中，可以縮短洞察時間，並增強在藥物篩選和先導化合物的決策能力。公司還應提供靈活的商業模式，例如服務合約和基於績效的契約，以適應學術、臨床和工業買家不斷變化的預算偏好。

最後，領導者應採用透明的整體擁有成本訊息，並提供強大的售後支援、培訓和檢驗服務。這些措施不僅可以提高顧客滿意度，還能透過強化硬體、耗材、服務和軟體在提供可靠篩檢結果方面的綜合價值，保障收益來源。

專家訪談、技術文獻綜述和交叉檢驗的嚴格結合，為篩檢技術、工作流程和採購動態提供了均衡的見解

本報告整合了主要和次要研究方法，旨在提供關於高通量定序 (HTS) 動態的平衡且基於證據的觀點。主要研究包括對該領域思想領袖的深入訪談，包括儀器製造商、耗材供應商、軟體供應商、服務供應商、學術研究人員和採購專業人士，從而就採用促進因素、痛點和策略重點提供定性見解。這些訪談旨在捕捉現實世界的決策標準，並檢驗該領域觀察到的新興趨勢。

二次研究包括系統性地回顧同行評審文獻、監管指南、技術規範、產品白皮書和會議論文集，旨在提供技術發展背景並檢驗性能聲明。透過平台功能、檢測類型和最終用戶需求的比較分析，我們形成了細分邏輯，並整合了跨領域主題。對主要和次要輸入進行三角測量，使我們能夠對供應鏈影響、關稅影響和區域採用模式進行有力的解讀。

在整個研究過程中，我們特別關注可重複性指標、檢測驗證實踐和資料管理方法，以反映對實際應用影響最大的因素。當缺乏獨特的性能數據時，我們會承認其局限性和不確定性，並在現有證據的範圍內提出可行的建議。

整合解決方案、對可重複性的關注以及協作採購構成了將高通量篩檢的進步轉化為一致發現結果的策略基礎

高通量篩檢正處於曲折點，技術進步、供應鏈現狀和不斷發展的研發模式交織在一起，重塑策略重點。微射流、實驗室晶片和無標定檢測技術的日趨成熟，擴展了可大規模進行的檢測方法，而液體處理和孔板形式的改進則使工作流程更加高效、可重複。同時，關稅和區域產能建設加劇了採購壓力，需要更複雜的採購和夥伴關係策略。

對於學術、臨床和產業相關人員，未來的發展方向是專注於整合解決方案，將強大的耗材、適應性強的儀器與檢驗的服務和先進的分析技術相結合。這種方法將降低營運風險，提高篩檢結果的轉換相關性，並加快先導化合物發現和安全性評估的決策。戰略合作、區域支援基礎設施和透明的檢驗實踐對於將技術潛力轉化為一致的科學成果至關重要。

摘要，優先考慮互通性、數據品質和靈活參與模式的組織將最有能力利用 HTS 創新浪潮，並將其篩檢投資轉化為永續的藥物發現成果。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 對基於 3D 類器官的高通量平台的需求不斷成長，這些平台可重現人體組織微環境
  • 透過在檢測設計中使用人工智慧和機器學習來提高篩檢通量和準確性
  • 擴展雲端基礎的數據分析解決方案，用於即時高通量篩檢數據解釋
  • 篩檢工作流程中的機器人自動化和實驗室資訊管理系統的實施
  • 擴大高內涵成像系統用於腫瘤藥物篩檢的連接複用細胞分析
  • 螢光和無標定檢測方法的使用增加了表現型篩檢試驗的靈敏度。
  • 微流體和液滴平台的整合實現了單細胞高通量藥物發現
  • 擴展 CRISPR-Cas9 全基因組篩檢技術用於腫瘤學標靶識別
  • 基於 3D 類器官的篩檢平台，可大規模增強組織特異性藥物反應建模
  • 基於微流體液滴的篩檢架構，可在藥物發現試驗中實現單細胞解析度

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 高通量篩檢市場（依產品類型）

  • 耗材
    • 實驗室設備
    • 試劑和檢測試劑套件
  • 裝置
    • 檢測系統
    • 液體處理系統
  • 服務
    • 檢測方法開發和檢驗
    • 篩檢
  • 軟體
    • 化合物管理
    • 數據分析

9. 高通量篩檢市場（依技術）

  • 基於細胞的檢測
    • 螢光成像盤式分析儀分析
    • 基於報告基因的檢測
  • 實驗室晶片技術（LOC）
  • 無標定技術
  • 基於微流體

10. 高通量篩檢市場（依板型）

  • 1536孔盤
  • 384孔盤
  • 96孔盤

第 11 章高通量篩檢市場（按應用）

  • 藥物研發
  • 基因組學和蛋白​​質組學
  • 分子篩檢
  • 毒理學和安全評估

第 12 章：高篩檢市場（依最終用戶分類）

  • 學術研究機構
  • 合約研究組織
  • 醫院和診斷實驗室
  • 製藥和生物技術公司

13. 高通量篩檢市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 14 章。高通量篩檢市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 高通量篩檢市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Agilent Technologies, Inc.
    • Aurora Biomed, Inc.
    • Bio-Rad Laboratories, Inc.
    • Biomat Srl
    • BMG LABTECH GmbH
    • BRAND GMBH+CO KG
    • Charles River Laboratories International, Inc.
    • Corning Incorporated
    • Creative Biolabs, Inc.
    • Danaher Corporation
    • DIANA Biotechnologies, as
    • Eppendorf SE
    • EUROFINS SCIENTIFIC SE
    • Gilson Company, Inc.
    • Hamilton Company
    • HighRes BioSolutions, Inc.
    • Lonza Group AG
    • Merck KGaA
    • Mettler Toledo International, Inc.
    • PerkinElmer, Inc.
    • Revvity, Inc.
    • Sartorius AG
    • Tecan Trading AG
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: MRR-501246436FA8

The High-Throughput Screening Market is projected to grow by USD 66.05 billion at a CAGR of 11.96% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 26.75 billion
Estimated Year [2025] USD 29.79 billion
Forecast Year [2032] USD 66.05 billion
CAGR (%) 11.96%

An evolved high-throughput screening era emphasizing assay fidelity, automation flexibility, and data integrity to accelerate discovery pipelines

High-throughput screening (HTS) has evolved from a niche automation capability into a cornerstone of contemporary drug discovery and translational research, enabling institutions to rapidly interrogate chemical space and biological phenotypes at unprecedented scale. Across laboratories, HTS workflows now integrate advanced detection systems, automated liquid handling, and data management platforms that together compress timelines from target identification to lead selection. As organizations seek to accelerate pipelines and reduce attrition, screening capabilities are increasingly judged not only on throughput but on flexibility, assay fidelity, and the quality of the data that informs downstream decisions.

The convergence of consumables innovation, instrument sophistication, service models, and analytical software has broadened the value proposition of HTS beyond simple large-scale testing. Consumables such as specialized labware and reagent kits are engineered to optimize assay robustness, while detection and liquid handling platforms are being designed to support miniaturized plate formats and complex cell-based readouts. Meanwhile, service providers offering assay development, validation, and end-to-end screening enable organizations without in-house capacity to leverage HTS capabilities rapidly, and software tools for compound management and data analysis are essential to manage the volume and complexity of screening outputs.

Taken together, these dynamics are reshaping priorities for R&D leaders, who now prioritize assay scalability, data integrity, and cross-platform interoperability. This report synthesizes the key technological, regulatory, and commercial drivers that are defining HTS strategy and capability development across academic, clinical, and industrial settings, offering a clear roadmap for decision-makers aiming to translate screening investments into measurable therapeutic and discovery outcomes.

Technological convergence, advanced analytics, and service models are reshaping screening workflows toward higher fidelity and translational relevance

The HTS landscape is undergoing transformative shifts driven by technological maturation, changing R&D models, and the imperative for enhanced data quality. Advances in microfluidics and lab-on-a-chip technologies are enabling dramatic reductions in reagent consumption and facilitating single-cell and miniaturized assays that were previously impractical at scale. Label-free detection modalities are converging with imaging and high-content approaches, creating hybrid readouts that capture phenotypic complexity while preserving throughput. These technological progressions are supported by improvements in liquid handling precision and plate formats, which together allow a broader array of assay types to be executed in smaller volumes without sacrificing reproducibility.

Alongside instrumentation, software and data analytics have shifted from peripheral tools to central pillars of HTS workflows. Compound management systems that integrate with screening platforms now ensure sample traceability and reduce error, while advanced data analysis pipelines-incorporating machine learning and pattern recognition-enhance hit identification and triage. The rise of contract research organizations and service-based screening models has also changed adoption patterns, enabling organizations to access specialized assays and validation services without capital-intensive investments. These shifts encourage portfolio-level experimentation and support adaptive R&D strategies.

Regulatory and quality expectations are simultaneously tightening, prompting suppliers to emphasize assay validation, documentation, and reproducibility. As a result, decision-makers increasingly favor integrated solutions that deliver robustness across consumables, instruments, services, and software. This confluence of developments is redefining what constitutes competitive advantage in HTS, placing a premium on interoperability, translational relevance, and the ability to generate high-confidence data that accelerates downstream development.

Tariff-driven procurement restructuring and supply chain resilience measures are redefining vendor selection, sourcing, and platform decisions in screening operations

United States tariff measures enacted and proposed for 2025 have introduced material considerations for procurement strategies, supply chain resilience, and cost structures within HTS ecosystems. Tariffs on certain categories of instrumentation and imported laboratory consumables have driven procurement teams to reassess sourcing strategies, balancing the need for specific product performance against the financial and logistical implications of cross-border transactions. As a result, organizations have placed greater emphasis on vendor diversification, local distributor relationships, and longer lead-time planning to mitigate exposure to tariff-related delays and price volatility.

In response to tariff pressures, some institutions have increased collaboration with domestic manufacturers and service providers to hedge against supply chain disruptions. This has accelerated interest in modular platforms that can be upgraded or serviced locally, and heightened scrutiny of suppliers' end-to-end sourcing maps. Procurement professionals are also evaluating total cost of ownership more rigorously, factoring in not only initial purchase price but also maintenance, consumable compatibility, and the potential for tariff-driven cost fluctuations.

Moreover, tariffs have spurred innovation in procurement strategies, including pooled purchasing across academic consortia and the use of contract research partnerships to obtain specialized capabilities without transferring capital expense. These adaptations maintain scientific momentum while managing financial impact. Looking ahead, the interplay between trade policy and strategic sourcing will continue to influence vendor selection, platform standardization, and the geography of HTS capability development.

Cross-cutting segmentation analysis reveals how product, technology, plate format, application, and end-user dynamics interact to shape adoption and value realization

Segmentation insights reveal differentiated demand drivers and technology pairings that inform product development and commercialization strategies. Within product type segmentation, consumables such as specialized labware and reagents and assay kits are critical to assay performance and are often the differentiator in reproducibility, while instruments comprising detection systems and liquid handling systems set the ceiling for throughput and precision. Services that encompass assay development and validation as well as screening create pathways for organizations to access bespoke capabilities without heavy capital outlay, and software offerings covering compound management and data analysis are essential to convert raw screening outputs into actionable candidate profiles. These product-level dynamics create interdependencies where consumable optimization, instrument compatibility, and software workflows collectively determine end-to-end assay success.

Technology segmentation highlights the growing prominence of cell-based assays, including fluorometric imaging plate reader assays and reporter-based assays, which are favored for their biological relevance. Parallel advances in lab-on-a-chip and microfluidics based approaches support miniaturized, higher-content assays that reduce reagent use and enable novel experimental designs, while label-free technologies offer complementary kinetic and mechanistic insights. Choices in plate format segmentation-ranging from high-density 1536-well plates to 384-well and 96-well formats-reflect trade-offs between throughput, data quality, and assay complexity, with higher-density plates suitable for large compound libraries and lower-density formats preferred for complex or primary-cell assays.

Application segmentation underscores that drug discovery, genomics and proteomics, molecular screening, and toxicology and safety assessment each impose distinct requirements on throughput, data fidelity, and assay design. End user segmentation shows that academic and research institutes, contract research organizations, hospitals and diagnostic labs, and pharmaceutical and biotechnology companies have diverse priorities tied to budget cycles, regulatory needs, and timelines. Understanding these segmentation layers enables vendors and purchasers to align product roadmaps, service offerings, and support models with the nuanced demands of each user cohort.

Regional innovation ecosystems and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific drive differentiated adoption and partnership strategies

Regional dynamics in the HTS landscape are shaped by distinct innovation ecosystems, regulatory environments, and commercial infrastructures across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, strong pharmaceutical and biotech clusters, coupled with advanced academic research networks, sustain demand for both cutting-edge instrumentation and comprehensive service offerings. Investment in translational research and a large base of contract research organizations create synergies that accelerate technology adoption and collaborative screening projects.

Europe, the Middle East & Africa present a heterogeneous picture where regulatory rigor and strong academic institutions drive high standards for assay validation and data quality. Local manufacturing capabilities in certain European countries support resilient supply chains, and collaborative research initiatives across borders foster technology transfer and standardization efforts. In markets across the Middle East and Africa, concentrated investments in diagnostic capacity and regional centers of excellence are gradually expanding the base of sophisticated screening users.

Asia-Pacific is characterized by rapid capacity expansion, substantial investments in biotech and pharmaceutical manufacturing, and growing internal demand for both instruments and consumables. Domestic suppliers in several Asia-Pacific countries are increasingly competitive on price and are improving on quality, prompting multinational vendors to adapt their regional strategies. Across all regions, cross-border collaboration and knowledge exchange are driving harmonization of best practices, even as local regulatory and procurement nuances continue to influence adoption pathways and partnership structures.

Integrated vendor strategies combining modular instruments, reliable consumables, validated services, and advanced analytics are defining competitive differentiation

Leading companies across the HTS ecosystem are focusing on integrated value propositions that combine hardware performance, consumable reliability, service expertise, and advanced software capabilities. Instrument manufacturers are expanding modular portfolios to support both high-density screening and complex phenotypic assays, prioritizing platform interoperability and retrofitability so that existing workflows can be upgraded without disruptive capital replacement. Suppliers of reagents and labware are investing in formulation improvements and quality control to reduce batch variability and enhance inter-assay consistency, recognizing that reagent performance directly influences hit reproducibility and downstream validation success.

Service providers are differentiating through deep assay development expertise, regulatory-grade validation processes, and flexible engagement models that range from standalone campaigns to long-term partnerships. Software vendors are embedding analytics, visualization, and machine learning into compound management and data analysis solutions, enabling more rapid hit triage and richer biological interpretation. Across the competitive landscape, strategic collaborations and distribution partnerships are common as companies seek to assemble comprehensive solutions that address enterprise pain points related to throughput, data integrity, and cross-platform compatibility.

Companies that demonstrate responsiveness to procurement pressures-such as local support infrastructure and total cost of ownership transparency-tend to gain traction with institutional buyers. Those that invest in partnerships with academic centers and CROs to validate translational relevance of their platforms build credibility among translational researchers and commercial developers. Overall, the most successful firms balance technological leadership with service excellence and pragmatic deployment models to maximize adoption across diverse end users.

Practical strategic moves for leaders to advance interoperability, regional support, validation rigor, and flexible commercial models to win adoption

Industry leaders should prioritize interoperability, reproducibility, and strategic partnerships to capture value as HTS evolves. Investments in platform modularity and upgrade pathways reduce friction for adopters and protect installed-base relationships, enabling customers to expand capabilities without wholesale replacement. Similarly, establishing robust quality control standards for consumables and transparent validation protocols builds trust with R&D buyers who demand reproducibility across sites and studies. By aligning product roadmaps with end-user workflows and compatibility requirements, suppliers can lower barriers to adoption and increase lifetime customer value.

Building regional service footprints and trusted distributor networks mitigates procurement risks and counters tariff-induced supply chain pressures. Collaborations with academic centers and CROs can accelerate real-world validation, broaden addressable use cases, and create referral pathways into long-term commercial relationships. On the software side, embedding analytics and machine learning into compound management and data analysis reduces time-to-insight and enhances decision-making across hit selection and lead optimization. Firms should also offer flexible commercial models, including service subscriptions and outcome-aligned contracts, to meet the evolving budgetary preferences of academic, clinical, and industrial buyers.

Finally, leaders should adopt transparent total cost of ownership messaging and provide robust post-sale support, training, and validation services. These measures not only improve customer satisfaction but also protect revenue streams by reinforcing the value of integrated hardware, consumables, services, and software in delivering high-confidence screening outcomes.

A rigorous blend of expert interviews, technical literature review, and cross-validation delivers balanced insights into screening technologies, workflows, and sourcing dynamics

This report synthesizes primary and secondary research methodologies to ensure a balanced and evidence-based perspective on HTS dynamics. Primary research comprised in-depth interviews with thought leaders across instrument manufacturing, consumables supply, software vendors, service providers, academic researchers, and procurement professionals, providing qualitative insights into adoption drivers, pain points, and strategic priorities. These conversations were conducted to capture real-world decision criteria and to validate emerging trends observed in the field.

Secondary research involved systematic review of peer-reviewed literature, regulatory guidance, technical specifications, product white papers, and conference proceedings to contextualize technological developments and validate performance claims. Comparative analysis of platform capabilities, assay types, and end-user requirements informed segmentation logic and allowed the synthesis of cross-cutting themes. Triangulation of primary and secondary inputs ensured robust interpretation of supply chain implications, tariff impacts, and regional adoption patterns.

Throughout the research process, special attention was given to reproducibility metrics, assay validation practices, and data management approaches to reflect the factors that most influence practical adoption. Limitations and uncertainties were acknowledged where proprietary performance data were unavailable, and recommendations are framed to be actionable within the bounds of accessible evidence.

Integrated solutions, reproducibility focus, and collaborative sourcing form the strategic foundation for turning high-throughput screening advances into consistent discovery outcomes

High-throughput screening stands at an inflection point where technological advances, supply chain realities, and evolving R&D models intersect to reshape strategic priorities. The maturation of microfluidics, lab-on-a-chip, and label-free detection is expanding the repertoire of assays that can be executed at scale, while improvements in liquid handling and plate formats enable more efficient and reproducible workflows. At the same time, procurement pressures-exacerbated by tariff dynamics-and regional capability building necessitate more sophisticated sourcing and partnership strategies.

For stakeholders across academic, clinical, and industrial settings, the path forward emphasizes integrated solutions that pair robust consumables and adaptable instruments with validated services and advanced analytics. Such approaches reduce operational risk, increase the translational relevance of screening outputs, and accelerate decision-making in lead discovery and safety assessment. Strategic collaboration, regional support infrastructure, and transparent validation practices will be critical in converting technological potential into consistent scientific outcomes.

In summary, organizations that prioritize interoperability, data quality, and flexible engagement models will be best positioned to harness the current wave of HTS innovation and translate screening investments into sustainable discovery performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing demand for 3D organoid-based high-throughput platforms replicating human tissue microenvironments
  • 5.2. Adoption of artificial intelligence and machine learning-driven assay design improving screening throughput and accuracy
  • 5.3. Expansion of cloud-based data analytics solutions for real-time high-throughput screening data interpretation
  • 5.4. Implementation of robotic automation and laboratory information management systems in screening workflows
  • 5.5. Scale-up of high-content imaging systems for multiplexed cellular analysis in oncology drug screening
  • 5.6. Use of fluorescence and label-free detection methods enhancing sensitivity in phenotypic screening assays
  • 5.7. Integration of microfluidics and droplet-based platforms enabling single-cell high-throughput drug discovery
  • 5.8. Expansion of CRISPR-Cas9 genome-wide screening techniques for target identification in oncology
  • 5.9. 3D organoid-based screening platforms enhancing tissue-specific drug response modeling at scale
  • 5.10. Microfluidic droplet-based screening architectures enabling single-cell resolution in drug discovery assays

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. High-Throughput Screening Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Labware
    • 8.1.2. Reagents & Assay Kits
  • 8.2. Instruments
    • 8.2.1. Detection Systems
    • 8.2.2. Liquid Handling Systems
  • 8.3. Services
    • 8.3.1. Assay Development & Validation
    • 8.3.2. Screening
  • 8.4. Software
    • 8.4.1. Compound Management
    • 8.4.2. Data Analysis

9. High-Throughput Screening Market, by Technology

  • 9.1. Cell-Based Assays
    • 9.1.1. Fluorometric Imaging Plate Reader Assays
    • 9.1.2. Reporter based Assays
  • 9.2. Lab-on-a-chip Technology (LOC)
  • 9.3. Label-free Technology
  • 9.4. Microfluidics Based

10. High-Throughput Screening Market, by Plate Format

  • 10.1. 1536-well plate
  • 10.2. 384-well plate
  • 10.3. 96-well plate

11. High-Throughput Screening Market, by Application

  • 11.1. Drug Discovery
  • 11.2. Genomics & Proteomics
  • 11.3. Molecular Screening
  • 11.4. Toxicology & Safety Assessment

12. High-Throughput Screening Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Contract Research Organizations
  • 12.3. Hospitals & Diagnostic Labs
  • 12.4. Pharmaceutical & Biotechnology Companies

13. High-Throughput Screening Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. High-Throughput Screening Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. High-Throughput Screening Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Agilent Technologies, Inc.
    • 16.3.2. Aurora Biomed, Inc.
    • 16.3.3. Bio-Rad Laboratories, Inc.
    • 16.3.4. Biomat S.r.l
    • 16.3.5. BMG LABTECH GmbH
    • 16.3.6. BRAND GMBH + CO KG
    • 16.3.7. Charles River Laboratories International, Inc.
    • 16.3.8. Corning Incorporated
    • 16.3.9. Creative Biolabs, Inc.
    • 16.3.10. Danaher Corporation
    • 16.3.11. DIANA Biotechnologies, a.s
    • 16.3.12. Eppendorf SE
    • 16.3.13. EUROFINS SCIENTIFIC SE
    • 16.3.14. Gilson Company, Inc.
    • 16.3.15. Hamilton Company
    • 16.3.16. HighRes BioSolutions, Inc.
    • 16.3.17. Lonza Group AG
    • 16.3.18. Merck KGaA
    • 16.3.19. Mettler Toledo International, Inc.
    • 16.3.20. PerkinElmer, Inc.
    • 16.3.21. Revvity, Inc.
    • 16.3.22. Sartorius AG
    • 16.3.23. Tecan Trading AG
    • 16.3.24. Thermo Fisher Scientific Inc.
    • 16.3.25. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. HIGH-THROUGHPUT SCREENING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. HIGH-THROUGHPUT SCREENING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HIGH-THROUGHPUT SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 297. E